Clinical Trial Update: AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating fludarabine and cytarabine chemotherapy for Acute Myeloid Leukemia with AML1-ETO fusion expression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Changhai Hospital | Conditions: Acute Myeloid Leukemia, AML1-ETO Fusion Protein Expression | Phase 4 | Status: UNKNOWN